Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic
<b>Background</b>: Although COVID-19 vaccination has been effective in reducing severe illness and mortality, its differential clinical behavior in vaccinated and unvaccinated individuals during the early stages of the pandemic-especially in settings with partial coverage and real-world conditions-remains insufficiently characterized. <b>Objective</b>: To assess differences in clinical presentation, comorbidity prevalence, hospitalization, and mortality between vaccinated and unvaccinated patients diagnosed with SARS-CoV-2 during the early phase of the pandemic. <b>Methods</b>: An analytical cross-sectional study was conducted using 4625 electronic medical records of patients diagnosed with COVID-19 in Guerrero, Mexico, between 1 January and 31 December 2021. Variables included vaccination status, age, sex, comorbidities, symptom severity, clinical outcomes, and mortality. Statistical analyses involved chi-square tests, logistic regression for hospitalization probability, and Cox proportional hazards models for mortality risk. <b>Results</b>: Of the patients analyzed, 31.45% had received at least one vaccine dose. Fever, headache, cough, and anosmia were more frequent among vaccinated individuals (<i>p</i> < 0.001). Prostration and chest pain were strongly associated with hospitalization in both groups. In unvaccinated patients, smoking (OR = 4.75), obesity (OR = 3.85), and hypertension (OR = 2.94) increased hospitalization risk. Among vaccinated patients, diabetes mellitus (OR = 3.62) and hypertension (OR = 2.88) were key predictors. Vaccination was significantly associated with lower odds of hospitalization (OR = 0.38; 95% CI: 0.26-0.55) and reduced mortality risk (HR = 0.24; 95% CI: 0.08-0.71). <b>Conclusions</b>: Vaccination status was a significant protective factor for both hospitalization and mortality; however, clinical symptoms and comorbidity-related risks varied, highlighting the need for individualized patient management strategies.
Authors
- Juan Manuel Sánchez-Rebolledo
- Eduardo López‐Ortiz (ORCID: https://orcid.org/0000-0002-0237-7480)
- Gabriela García-Morales (ORCID: https://orcid.org/0000-0002-9814-5202)
- Geovani López-Ortiz (ORCID: https://orcid.org/0000-0003-0280-0012)
- Anel Gómez‐García (ORCID: https://orcid.org/0000-0002-9158-1095)
- Brenda Garduño-Orbe
- Paola Selene Palma-Ramírez
- Alexis Emigdio-Loeza
Institutions
- Mexican Social Security Institute (MX)
- Hospital de Especialidades (MX)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2025-06-27
- DOI
- https://doi.org/10.3390/idr17040074
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79